These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 25864532)

  • 1. Ganglioside, disialosyl globopentaosylceramide (DSGb5), enhances the migration of renal cell carcinoma cells.
    Kawasaki Y; Ito A; Kakoi N; Shimada S; Itoh J; Mitsuzuka K; Arai Y
    Tohoku J Exp Med; 2015 May; 236(1):1-7. PubMed ID: 25864532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ganglioside DSGb5, preferred ligand for Siglec-7, inhibits NK cell cytotoxicity against renal cell carcinoma cells.
    Kawasaki Y; Ito A; Withers DA; Taima T; Kakoi N; Saito S; Arai Y
    Glycobiology; 2010 Nov; 20(11):1373-9. PubMed ID: 20663960
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathological significance of ganglioside DSGb5 expression in renal cell carcinoma.
    Itoh J; Ito A; Shimada S; Kawasaki Y; Kakoi N; Saito H; Mitsuzuka K; Watanabe M; Satoh M; Saito S; Arai Y
    Glycoconj J; 2017 Apr; 34(2):267-273. PubMed ID: 28205070
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ganglioside disialosyl globopentaosylceramide is an independent predictor of PSA recurrence-free survival following radical prostatectomy.
    Shimada S; Ito A; Kawasaki Y; Kakoi N; Taima T; Mitsuzuka K; Watanabe M; Saito S; Arai Y
    Prostate Cancer Prostatic Dis; 2014 Jun; 17(2):199-205. PubMed ID: 24637536
    [TBL] [Abstract][Full Text] [Related]  

  • 5. COP1 is downregulated in renal cell carcinoma (RCC) and inhibits the migration of RCC ACHN cells in vitro.
    Ta L; Xuan C; Xing N; Zhu X
    Mol Med Rep; 2016 Aug; 14(2):1371-8. PubMed ID: 27278120
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cyclic AMP responsive element-binding protein induces metastatic renal cell carcinoma by mediating the expression of matrix metallopeptidase-2/9 and proteins associated with epithelial-mesenchymal transition.
    Wang X; Cui H; Lou Z; Huang S; Ren Y; Wang P; Weng G
    Mol Med Rep; 2017 Jun; 15(6):4191-4198. PubMed ID: 28487942
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations in enhancer of zeste homolog 2, matrix metalloproteinase-2 and tissue inhibitor of metalloproteinase-2 expression are associated with ex vivo and in vitro bone metastasis in renal cell carcinoma.
    Wang J; Ren Y; Guo X; Cheng H; Ye Y; Qi J; Yang C; You H
    Mol Med Rep; 2015 May; 11(5):3585-92. PubMed ID: 25571919
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Ghrelin promotes renal cell carcinoma metastasis via Snail activation and is associated with poor prognosis.
    Lin TC; Liu YP; Chan YC; Su CY; Lin YF; Hsu SL; Yang CS; Hsiao M
    J Pathol; 2015 Sep; 237(1):50-61. PubMed ID: 25925728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
    Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
    Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemoenzymatic synthesis of the oligosaccharide moiety of the tumor-associated antigen disialosyl globopentaosylceramide.
    't Hart IME; Li T; Wolfert MA; Wang S; Moremen KW; Boons GJ
    Org Biomol Chem; 2019 Aug; 17(31):7304-7308. PubMed ID: 31339142
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of RNA interference of the expression of HMGA2 on the proliferation and invasion ability of ACHN renal cell carcinoma cells.
    Liu Y; Fu QZ; Pu L; Song LL; Wang YY; Liu J; Wang ZL; Wang ZM
    Mol Med Rep; 2017 Oct; 16(4):5107-5112. PubMed ID: 28849119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CXC chemokine receptor 4 is essential for maintenance of renal cell carcinoma-initiating cells and predicts metastasis.
    Gassenmaier M; Chen D; Buchner A; Henkel L; Schiemann M; Mack B; Schendel DJ; Zimmermann W; Pohla H
    Stem Cells; 2013 Aug; 31(8):1467-76. PubMed ID: 23630186
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Expression of BTS-2 Enhances Cell Growth and Invasiveness in Renal Cell Carcinoma.
    Pham QT; Oue N; Yamamoto Y; Shigematsu Y; Sekino Y; Sakamoto N; Sentani K; Uraoka N; Tiwari M; Yasui W
    Anticancer Res; 2017 Jun; 37(6):2853-2860. PubMed ID: 28551621
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dicer is down-regulated in clear cell renal cell carcinoma and in vitro Dicer knockdown enhances malignant phenotype transformation.
    Ma X; Fan Y; Gao Y; Zhang Y; Huang Q; Ai Q; Ni D; Chen W; Zhang P; Song E; Wang B; Shi T; Zheng T; Zhang X
    Urol Oncol; 2014 Jan; 32(1):46.e9-17. PubMed ID: 24094887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EphA2 Is a Potential Player of Malignant Cellular Behavior in Non-Metastatic Renal Cell Carcinoma Cells but Not in Metastatic Renal Cell Carcinoma Cells.
    Cho MC; Cho SY; Yoon CY; Lee SB; Kwak C; Kim HH; Jeong H
    PLoS One; 2015; 10(7):e0130975. PubMed ID: 26177500
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wilms' tumor 1-associating protein promotes renal cell carcinoma proliferation by regulating CDK2 mRNA stability.
    Tang J; Wang F; Cheng G; Si S; Sun X; Han J; Yu H; Zhang W; Lv Q; Wei JF; Yang H
    J Exp Clin Cancer Res; 2018 Feb; 37(1):40. PubMed ID: 29482572
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inverse relationship of expression between GM3 and globo-series ganglioside in human renal cell carcinoma.
    Saito S; Nojiri H; Satoh M; Ito A; Ohyama C; Orikasa S
    Tohoku J Exp Med; 2000 Apr; 190(4):271-8. PubMed ID: 10877509
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Reduced L/B/K alkaline phosphatase gene expression in renal cell carcinoma: plausible role in tumorigenesis.
    Sharma U; Pal D; Singh SK; Kakkar N; Prasad R
    Biochimie; 2014 Sep; 104():27-35. PubMed ID: 24909115
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR‑205 suppresses cell proliferation, invasion, and metastasis via regulation of the PTEN/AKT pathway in renal cell carcinoma.
    Wang H; Chen B; Duan B; Zheng J; Wu X
    Mol Med Rep; 2016 Oct; 14(4):3343-9. PubMed ID: 27498834
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Vitamin D receptor suppresses proliferation and metastasis in renal cell carcinoma cell lines via regulating the expression of the epithelial Ca2+ channel TRPV5.
    Chen Y; Liu X; Zhang F; Liao S; He X; Zhuo D; Huang H; Wu Y
    PLoS One; 2018; 13(4):e0195844. PubMed ID: 29659618
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.